Geneva, Aug. 17 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129673) titled 'Comparison of the efficacy of 595nm pulsed dye laser with different endpoint reactions in treating facial telangiectasia' on Aug. 7.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shanghai Skin Disease Hospital
Condition:
Facial Telangiectasia
Intervention:
Purpura:Pulsed dye laser treatment for half face with purpura as the endpoint reaction
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2023-10-18
Target Sample Size: Purpura:25;Sub-purpura:25;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=30386...